Lymphocytic surface markers in lymphoid leukemoid reactions

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Mononuclear cell surface markers are key for leukemia and lymphoma classification.
• These markers can also differentiate neoplastic from reactive conditions.
• Interpreting markers requires careful consideration of morphology and clinical context.

Purpose of the Study:

• To explore the utility of mononuclear cell surface markers in distinguishing neoplastic from reactive lymphoid conditions.
• To highlight challenges and nuances in marker interpretation for various clinical scenarios.
• To emphasize the importance of integrated diagnostic approaches.

Main Methods:

• Analysis of mononuclear cell surface marker expression in peripheral blood, lymph nodes, skin, and bone marrow.
• Comparison of marker profiles in neoplastic versus reactive lymphoid proliferations.
• Consideration of light chain restriction, T-cell subsets, and specific antigens (e.g., CD10, TdT).

Main Results:

• Reactive lymphocytosis often shows activated T-suppressor/cytotoxic cells, with exceptions like pertussis (T-helper cells).
• Lack of light chain restriction on B-cells suggests non-neoplastic disorders.
• Reactive lymphadenopathy typically exhibits T-cell predominance with normal T-helper/T-suppressor ratios and kappa/lambda light chain ratios.

Conclusions:

• Mononuclear cell markers are valuable but require cautious interpretation, especially in bone marrow and skin infiltrates.
• Distinguishing reactive from neoplastic conditions can be challenging and may necessitate genotypic analysis.
• Integrated interpretation of immunologic markers and tissue morphology is essential for accurate diagnosis.